Although IgA antibodies are unable to activate the classical complement pathway, recent insights suggest they may be implicated in the activation of the alternative complement pathway in lupus glomeruli [45], notwithstanding the fact that no antibody binding is usually required to such pathway. The gene discussed is CD79A; the disease is systemic lupus erythematosus.